Pivotal Bio Venture Partners Investment Advisor LLC Portfolio Holdings

Pivotal Bio Venture Partners Investment Advisor LLC

  • $109 Million
  • Q4 2024

Pivotal Bio Venture Partners Investment Advisor LLC has filed its 13F form on February 13, 2025 for Q4 2024 where it was disclosed a total value porftolio of $109 Million distributed in 11 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Vaxcyte, Inc. with a value of $57.6M, Arcutis Biotherapeutics, Inc. with a value of $29.5M, Inozyme Pharma, Inc. with a value of $12.5M, Recursion Pharmaceuticals, Inc. with a value of $4.03M, and Rallybio Corp with a value of $2.31M.

Examining the 13F form we can see an decrease of $18.1M in the current position value, from $127M to 109M.

Pivotal Bio Venture Partners Investment Advisor LLC is based out at San Francisco, CA

Below you can find more details about Pivotal Bio Venture Partners Investment Advisor LLC portfolio as well as his latest detailed transactions.

Portfolio value $109 Million
Healthcare: $109 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$4.33B
$57.6 Million 53.0% of portfolio
703,834
Q4 2024 Added 10.05%
$824M
$29.5 Million 27.17% of portfolio
2,120,508
Q3 2024 Added 3.89%
$48.2M
$12.5 Million 11.45% of portfolio
4,494,851
Q3 2023 Added 22.76%
$1.36B
$4.03 Million 3.7% of portfolio
595,518
Q4 2024 New
$23.1M
$2.31 Million 2.12% of portfolio
2,404,644
Q4 2022 Added 5.87%
$17.7M
$1.04 Million 0.96% of portfolio
1,891,467
Q1 2021 New
$68.4M
$941,000 0.87% of portfolio
560,595
Q1 2022 New
$27.1M
$795,000 0.73% of portfolio
864,197
Q3 2023 New
Oculis Holding Ag
-
$0 0.0% of portfolio
-
Q4 2024 Added 8.88%
Bioage Labs Inc
-
$0 0.0% of portfolio
-
Q4 2024 Added 23.83%
Zenas Biopharma Inc
-
$0 0.0% of portfolio
-
Q4 2024 Added 13.21%

Summary

  • Portfolio
  • No. of Stocks 11
  • Current Value $109 Million
  • Prior Value $127 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 13, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 1 stocks
  • Additional Purchases 4 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Pivotal Bio Venture Partners Investment Advisor LLC Portfolio

Follow Pivotal Bio Venture Partners Investment Advisor LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pivotal Bio Venture Partners Investment Advisor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pivotal Bio Venture Partners Investment Advisor LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email